Want to join the conversation?
$VAR 2Q15 10-Q: Revenues were $759.4MM vs. $778.5MM in 2Q14. Operating earnings were $146MM vs. $127.5MM in 2Q14. Net earnings were $106MM vs. $92.8MM in 2Q14. R&D expense was $59.3MM vs. $60.7MM in 2Q14. SG&A expense was $117.2MM vs. $115MM in 2Q14. OpEx was $176.5MM vs. $200.8MM in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?